Perinephric and epididymal fat affect hepatic metabolism in rats

Obesity

Volumn 20, Issue 1, 2012, Pages 151-156

  Ben Shlomo, Shani ^a   Einstein, Francine H ^b   Zvibel, Isabel ^a   Atias, Dikla ^a   Shlomai, Amir ^a   Halpern, Zamir ^a   Barzilai, Nir ^b   Fishman, Sigal ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPOCYTOKINE; FATTY ACID; GLUCOSE; INSULIN; LEPTIN; PROTEIN KINASE B; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATTY ACID BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID LIVER LEVEL; LIPID STORAGE; LIPOGENESIS; LIVER METABOLISM; LIVER PROTECTION; NONHUMAN; PERINEPHRIC AND EPIDIDYMAL VISCERAL FAT; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; DIET, HIGH-FAT; EPIDIDYMIS; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; KIDNEY; LIVER; MALE; OBESITY; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

RATTUS;

EID: 84655169538     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.261     Document Type: Article

References (27)

1. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010;51: 679-689.
2. Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005;42:987-1000. (Pubitemid 43112663)
3. Frayn KN. Adipose tissue as a buffer for daily lipid flux. Diabetologia 2002;45:1201-1210.
4. Huang-Doran I, Sleigh A, Rochford JJ, O'Rahilly S, Savage DB. Lipodystrophy: metabolic insights from a rare disorder. J Endocrinol 2010;207:245-255.
5. Yu YH, Ginsberg HN. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res 2005;96:1042-1052. (Pubitemid 40791376)
6. Marra F, Bertolani C. Adipokines in liver diseases. Hepatology 2009;50: 957-969.
7. Lafontan M, Girard J. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Diabetes Metab 2008;34:317-327.
8. Yang X, Smith U. Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia 2007;50:1127-1139. (Pubitemid 46701551)
9. Nov O, Kohl A, Lewis EC et al. Interleukin-1beta may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation. Endocrinology 2010;151:4247-4256.
10. Erion DM, Shulman GI. Diacylglycerol-mediated insulin resistance. Nat Med 2010;16:400-402.
11. Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 2010;375:2267-2277.
12. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991;14:1132-1143.
13. Rexrode KM, Carey VJ, Hennekens CH et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998;280:1843-1848. (Pubitemid 28544425)
14. Tamura S, Shimomura I. Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J Clin Invest 2005;115: 1139-1142. (Pubitemid 40629030)
15. Gabriely I, Ma XH, Yang XM et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 2002;51:2951-2958.
16. Fishman S, Muzumdar RH, Atzmon G et al. Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo. FASEB J 2007;21:53-60. (Pubitemid 46061355)
17. Cusi K. The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr Diab Rep 2010;10:306-315.
18. Fernández-Riejos P, Najib S, Santos-Alvarez J et al. Role of leptin in the activation of immune cells. Mediators Inflamm 2010;2010:568343.
19. Wang J, Obici S, Morgan K et al. Overfeeding rapidly induces leptin and insulin resistance. Diabetes 2001;50:2786-2791. (Pubitemid 33733130)
20. Petersen KF, Oral EA, Dufour S et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002;109:1345-1350. (Pubitemid 34546899)
21. Dobbins RL, Szczepaniak LS, Zhang W, McGarry JD. Chemical sympathectomy alters regulation of body weight during prolonged ICV leptin infusion. Am J Physiol Endocrinol Metab 2003;284:E778-E787. (Pubitemid 36323872)
22. Thörne A, Lönnqvist F, Apelman J, Hellers G, Arner P. A pilot study of longterm effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 2002;26: 193-199. (Pubitemid 34151196)
23. Fabbrini E, Tamboli RA, Magkos F et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology 2010;139:448-455.
24. Csendes A, Maluenda F, Burgos AM. A prospective randomized study comparing patients with morbid obesity submitted to laparotomic gastric bypass with or without omentectomy. Obes Surg 2009;19:490-494.
25. Atzmon G, Yang XM, Muzumdar R et al. Differential gene expression between visceral and subcutaneous fat depots. Horm Metab Res 2002;34: 622-628. (Pubitemid 36398696)
26. Einstein FH, Atzmon G, Yang XM et al. Differential responses of visceral and subcutaneous fat depots to nutrients. Diabetes 2005;54:672-678. (Pubitemid 40322069)
27. Lafontan M, Girard J. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Diabetes Metab 2008;34:317-327.